Hello, Guest!

CACI Completes Emergint Buy; Dan Allen, John Mengucci Comment

Dan Allen

CACI International (NYSE: CACI) has completed its acquisition of healthcare information technology firm Emergint Technologies for an undisclosed amount.

CACI said it aims for the acquisition to help grow its presence in the healthcare IT market.

President and CEO Dan Allen said Emergint brings established relationships with federal health organizations to CACI as public health organizations are increasingly focusing on data information exchange.

Emergint also brings offerings in data analytics, integration and analysis to CACI’s healthcare IT practice, said John Mengucci, CACI’s chief operating officer and president of U.S. operations.

CACI estimates Emergint’s 2012 revenues at around $42 million and expects the acquisition to increase its earnings per share during the first 12 months.

Emergint holds positions on contract vehicles with the Centers for Disease Control and Prevention, National Institutes of Health and Food and Drug Administration.

The 300-employee firm, founded in 1999 and based in Louisville, provides clients services in health data integration and analysis, management and IT consulting and data and records management.

Video of the Day

Related Articles